ICUI vs. NARI, ATRI, MMSI, HAE, ATEC, IRTC, ATRC, AXNX, TNDM, and LMAT
Should you be buying ICU Medical stock or one of its competitors? The main competitors of ICU Medical include Inari Medical (NARI), Atrion (ATRI), Merit Medical Systems (MMSI), Haemonetics (HAE), Alphatec (ATEC), iRhythm Technologies (IRTC), AtriCure (ATRC), Axonics (AXNX), Tandem Diabetes Care (TNDM), and LeMaitre Vascular (LMAT). These companies are all part of the "medical" sector.
Inari Medical (NASDAQ:NARI) and ICU Medical (NASDAQ:ICUI) are both mid-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, media sentiment, profitability, institutional ownership, valuation, community ranking, earnings, analyst recommendations and dividends.
In the previous week, Inari Medical and Inari Medical both had 1 articles in the media. ICU Medical's average media sentiment score of 1.54 beat Inari Medical's score of 0.00 indicating that Inari Medical is being referred to more favorably in the media.
87.8% of Inari Medical shares are owned by institutional investors. Comparatively, 91.5% of ICU Medical shares are owned by institutional investors. 11.9% of Inari Medical shares are owned by insiders. Comparatively, 7.5% of ICU Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Inari Medical has a net margin of -0.59% compared to Inari Medical's net margin of -1.25%. Inari Medical's return on equity of 6.53% beat ICU Medical's return on equity.
Inari Medical currently has a consensus price target of $82.00, suggesting a potential upside of 30.06%. ICU Medical has a consensus price target of $216.00, suggesting a potential upside of 150.43%. Given Inari Medical's higher probable upside, analysts plainly believe ICU Medical is more favorable than Inari Medical.
Inari Medical has a beta of 0.92, suggesting that its share price is 8% less volatile than the S&P 500. Comparatively, ICU Medical has a beta of 0.63, suggesting that its share price is 37% less volatile than the S&P 500.
ICU Medical received 330 more outperform votes than Inari Medical when rated by MarketBeat users. However, 69.44% of users gave Inari Medical an outperform vote while only 64.30% of users gave ICU Medical an outperform vote.
Inari Medical has higher earnings, but lower revenue than ICU Medical. Inari Medical is trading at a lower price-to-earnings ratio than ICU Medical, indicating that it is currently the more affordable of the two stocks.
Summary
Inari Medical beats ICU Medical on 9 of the 16 factors compared between the two stocks.
Get ICU Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for ICUI and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ICUI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartThis chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
ICU Medical Competitors List
Related Companies and Tools